227 related articles for article (PubMed ID: 8570625)
1. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.
Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Strominger JL; Wiley DC
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):734-8. PubMed ID: 8570625
[TBL] [Abstract][Full Text] [Related]
2. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
Murthy VL; Stern LJ
Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
[TBL] [Abstract][Full Text] [Related]
3. Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1.
Zavala-Ruiz Z; Sundberg EJ; Stone JD; DeOliveira DB; Chan IC; Svendsen J; Mariuzza RA; Stern LJ
J Biol Chem; 2003 Nov; 278(45):44904-12. PubMed ID: 12952957
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II molecule.
Fernández MM; Guan R; Swaminathan CP; Malchiodi EL; Mariuzza RA
J Biol Chem; 2006 Sep; 281(35):25356-64. PubMed ID: 16829512
[TBL] [Abstract][Full Text] [Related]
5. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
6. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
Kropshofer H; Bohlinger I; Max H; Kalbacher H
Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.
Stern LJ; Brown JH; Jardetzky TS; Gorga JC; Urban RG; Strominger JL; Wiley DC
Nature; 1994 Mar; 368(6468):215-21. PubMed ID: 8145819
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release.
Negroni MP; Stern LJ
PLoS One; 2018; 13(7):e0199704. PubMed ID: 29965980
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence.
Petersson K; Håkansson M; Nilsson H; Forsberg G; Svensson LA; Liljas A; Walse B
EMBO J; 2001 Jul; 20(13):3306-12. PubMed ID: 11432818
[TBL] [Abstract][Full Text] [Related]
10. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.
Kim J; Urban RG; Strominger JL; Wiley DC
Science; 1994 Dec; 266(5192):1870-4. PubMed ID: 7997880
[TBL] [Abstract][Full Text] [Related]
11. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
[TBL] [Abstract][Full Text] [Related]
12. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
Schulze MS; Anders AK; Sethi DK; Call MJ
PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
[TBL] [Abstract][Full Text] [Related]
13. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
[TBL] [Abstract][Full Text] [Related]
14. Model for the peptide-free conformation of class II MHC proteins.
Painter CA; Cruz A; López GE; Stern LJ; Zavala-Ruiz Z
PLoS One; 2008 Jun; 3(6):e2403. PubMed ID: 18545669
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.
Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Chi YI; Stauffacher C; Strominger JL; Wiley DC
Nature; 1994 Apr; 368(6473):711-8. PubMed ID: 8152483
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of a structural homology model for a class II histocompatibility protein, HLA-DR1: comparison to the crystal structure.
Nauss JL; Reid RH; Sadegh-Nasseri S
J Biomol Struct Dyn; 1995 Jun; 12(6):1213-33. PubMed ID: 7669268
[TBL] [Abstract][Full Text] [Related]
17. Cooperativity during the formation of peptide/MHC class II complexes.
Anderson MW; Gorski J
Biochemistry; 2005 Apr; 44(15):5617-24. PubMed ID: 15823020
[TBL] [Abstract][Full Text] [Related]
18. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
[TBL] [Abstract][Full Text] [Related]
19. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.
Malcherek G; Gnau V; Jung G; Rammensee HG; Melms A
J Exp Med; 1995 Feb; 181(2):527-36. PubMed ID: 7836909
[TBL] [Abstract][Full Text] [Related]
20. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
